January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
FDA Authorizes Use of Pfizer COVID-19 Vaccine Booster Dose in Children Aged 12 to 15 Years
Pending endorsement from the CDC, adolescents can now get a booster dose of the Pfizer-BioNTech vaccine, as authorized by an amendment to the original FDA EUA for the vaccine.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
The CDC Recommends Pfizer, Moderna COVID Vaccines over J&J
The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Persistent Dyspnea in Patients with Long COVID-19 May Indicate Heart Issues
New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.
Flu Called out by COVID as "Irrelevant," Flu Calls Press Conference, Issues Statement
COVID-19, in an attempt to bully Flu and potentially gain precious lung space in humans this year, provoked the veteran virus, labeling him as "irrelevant." Flu responds.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
FDA Extends Pfizer-BioNTech COVID-19 Vaccine Booster EUA to Cover 16-17-year-olds
Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 9, 2021
Pfizer: Protection Against Omicron Variant ‘Improved’ After 3 Doses of COVID-19 Vaccine
New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 8, 2021
Flu Takes Backseat to COVID-19: Survey of US Adults
Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 7, 2021
J&J COVID-19 Booster May Offer More Protection in Mix-and-Match Scenario
A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.
Influenza Virus: How well do you know this enemy?
The flu is well known to all primary care providers - but contributor Terry Brenneman, MD, created 6 questions on topics you might not ordinarily discuss. Quiz time.
Early Increase in Positive Flu Tests Seen Among Young Adults
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
New Analysis Projects Older Ages and Rising Number of Patients with HIV by 2030
Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 2, 2021
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 1, 2021
FDA Advisory Committee Narrowly Backs Merck’s Oral COVID-19 Antiviral
The 13-10 vote was not without controversy as panel members discussed concerns over the novel antiviral's safety risks and modest efficacy.
Omicron Variant Update: Notes on Headline News 12-1-2021
The Omicron variant of COVID-19 was today identified for the first time in the US, according to the CDC. Get a topline look at other recent breaking news in this slide show.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 30, 2021
Omicron Variant is Moving Quickly but Much Remains Unknown, says WHO
The Omicron variant of the SARS-CoV-2 virus is spreading quickly, jumping continents with infected travelers. The best protection remains vaccination and indoor precautions.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 23, 2021
COVID-19 Cases, Hospitalizations Up: Top 5 States Reporting Increases
COVID-19 cases are up by double digits in many states and hospitalizations have made big leaps in others. We report the top 5 in each category for the 7 days from 11/14-21.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
FDA, CDC Authorize Use of Pfizer, Moderna Booster Shots for Every US Adult
Booster doses for US adults at least 18 years of age are expected to be available as soon as this weekend.